Tumour development, histology and grade of breast cancers: Prognosis and progression

International Journal of Cancer

Volumn 66, Issue 4, 1996, Pages 413-419

  Tabar, Laszlo ^a   Fagerberg, Gunnar ^b   Chen, H H ^c   Duffy, S W ^c,d   Gad, A ^a  

^a FALUN HOSPITAL   (Sweden)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^c MRC BIOSTATISTICS UNIT   (United Kingdom)

^d MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER GRADING; CELL DIFFERENTIATION; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; TUMOR GROWTH;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; PROGNOSIS; SURVIVAL ANALYSIS; SWEDEN;

EID: 0029991802     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960516)66:4<413::AID-IJC1>3.0.CO;2-Z     Document Type: Article

References (35)

1. ANDERSON, T.J., LAMB, J., ALEXANDER, F., LUTZ, W., CHETTY, U., FORREST, A.P., KIRKPATRICK, A., MUIR, B., ROBERTS, M.M. and HUGGINS, A., Comparative pathology of prevalent and incident cancers detected by breast screening. Lancet, I, 519-523 (1986).
2. AUER, G., FALLENIUS, A., ERHARDT, K. and SUNDELIN, B., Progression of mammary adenocarcinoma as reflected by nuclear DNA content. Cytometry, 5, 420-425 (1984).
3. BLACK, M.M., BARCLAY, T.H.C. and HANKEY, B.F., Prognosis in breast cancer utilising histological characteristics of the primary tumour. Cancer, 36, 2048-2055 (1975).
4. BLOOM, H.J.G., Prognosis in carcinoma of the breast. Brit. J. Cancer, 4, 259-288 (1950a).
5. BLOOM, H.J.G., Further studies on prognosis of breast carcinoma. Brit. J. Cancer, 4, 347-367 (1950b).
6. BLOOM, H.J.G. and RICHARDSON, W.W., Histological grading and prognosis in breast cancer. Brit. J. Cancer, 11, 359-377 (1957).
7. BLUMEN, I., KOGAN, M. and MCCARTHY, P.J., The industrial mobility of labor as a probability process. Cornell University Press, Ithaca, NY (1955).
8. CARSTENS, P.H., GREENBERG, R.A., FRANCIS, D. and LYON, H., Tubular carcinoma of the breast. A long-term follow up. Histopathology, 9, 271-280 (1985).
9. CLAYTON, F., Pure mucinous carcinoma of the breast: morphological features and prognostic correlates. Hum. Pathol., 17, 34-39 (1986).
10. CONTESSO, G., MOURIESSE, H., FRIEDMAN, S., GÉNIN, J., SARRAZIN, D. and ROUESSE, J., The importance of histological grade in long-term prognosis of breast cancer. A study of 1,010 patients uniformly treated at the Institute Gustave Roussy. J. clin. Oncol., 5, 1378-1386 (1987).
11. COOPER, P.H.B., PATCHEFSKY, A.S. and KRALL, R.A., Tubular carcinoma of the breast. Cancer, 42, 2334-2342 (1978).
12. COWAN, W.K., HENRY, A.J., CORBET, I.P., REID, W.A. and HORNE, C.H.W., Immunohistochemical and other features of breast carcinomas presenting clinically compared with those detected by cancer screening. Brit. J. Cancer, 64, 780-784 (1991).
13. DAY, N.E., TABAR, L., DUFFY, S.W. and CHEN, H.H., Population breast cancer screening. (Letter). Lancet, 345, 853 (1995).
14. DUFFY, S.W., CHEN, H.H., TABAR, L. and DAY, N.E., Estimation of mean sojourn time in breast cancer screening using a Markov chain model of both entry to and exit from the preclinical detectable phase. Statist. Med., 14, 1531-1543 (1995).
15. DUFFY, S.W., TABAR, L., FAGERBERG, G., GAD, A., GRÖNTOFT, O., SOUTH, M.C. and DAY, N. E., Breast screening, prognostic factors and survival results from the Swedish two county study. Brit. J. Cancer, 64, 1133-1138 (1991).
16. ELLIS, I.O., GALEA, M., BROUGHTON, N., LOCKER, A., BLAMEY, R.W. and ELSTON, C.W., Pathological prognostic factors in breast cancer. II. Histological type. Relationship with survival in a large study with long-term follow-up. Histopathology, 20, 479-489 (1992).
17. ELSTON, C.W. and ELLIS, I.O., Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology, 19, 403-410 (1992).
18. FRYDMAN, H., Maximum likelihood estimation in the mover-stayer model. J. Amer. statist. Ass., 79, 632-638 (1984).
19. FUCHS, C. and GREENHOUSE, J.B., The EM algorithm for maximum likelihood estimation in the mover-stayer Model. Biometrics, 44, 605-613 (1988).
20. HAKAMA, M., and 12 OTHERS, Aggressiveness of screen-detected breast cancers. Lancet, 345, 221-224 (1995).
21. HATSCHEK, T., GRONTOFT, O., FAGERBERG, G., STAL, O., SULLIVAN, S., CARSTENSEN, J. and NORDENSKJÖLD, B., Cytometric and histopathologic features of tumours detected in a randomised mammography screening program: correlation and relative prognostic influence. Breast Cancer Res., 15, 149-160 (1990).
22. HAYBITTLE, J.L., BLAMEY, R.W., ELSTON, C.W., JOHNSON, J., DOYLE, P., CAMPBELL, F.G., NICHOLSON, R.I. and GRIFFITHS, K., A prognostic index in primary cancer. Brit. J. Cancer, 45, 361-366 (1982).
23. JOENSUU, H., TOIKKANEN, S. and KLEMI, P.J., Histological features, DNA content and prognosis of breast carcinoma found incidentally or in screening. Brit. J. Cancer, 64, 588-592 (1991).
24. LACROIX, H., IGLEHART, S.D., SKINNER, M.A. and KRAUS, M.M., Over-expression of erb B-2 or EGF receptor proteins present in early-stage mammary carcinoma is detected simultaneously in matched primary tumours and regional metastases. Oncogene, 4, 145-151 (1989).
25. LINELL, F., LJUNBERG, O. and ANDERSSON, I., Breast carcinoma aspects of early stages, progression and related problems. Acta pathol. microbiol. scand., Suppl. 272, 63-101 (1980).
26. MEYER, J.S. and WITTLIFF, J.L., Regional heterogeneity in breast carcinoma: thymidine labelling index, steroid hormone receptors, DNA ploidy. Int. J. Cancer, 47, 213 (1991).
27. MORGAN, T.M., ANESHENSEL, C.S. and CLARK, V.A., Parameter estimation for mover-stayer models. Sociol. Meth. Res., 11, 345-366 (1983).
28. PONTEN, J., HOLMBERG, L., TRICHOPOULOS, D., KALLIONIEMI, G.K., KVALE, G., WALLGREN, A. and TAYLOR-PAPADIMITRIOU, J., Biology and natural history of breast cancer. Int. J. Cancer, Suppl. 5, 5-21 (1990).
29. RAJAKARIA, R. and WALKER, R.A., Pathological and biological features of mammographically detected invasive breast carcinomas. Brit. J. Cancer, 71, 150-154 (1995).
30. SCARFF, R.W. and TORLONI, H., Histological typing of breast tumours. In: International histological classification of tumours, 2, World Health Organisation, Geneva (1968).
31. TABAR, L., FAGERBERG, G., CHEN, H.H., DUFFY, S.W., SMART, C.R., GAD, A. and SMITH, R.A., Efficacy of breast cancer screening by age: new results from Swedish two-county trial. Cancer, 75, 2507-2517 (1995).
32. TABAR, L., and 13 OTHERS, Reduction in mortality from breast cancer after mass screening with mammography. Lancet, 1, 829-832 (1985).
33. TEIXEIRA, M.R., PANDIS, N., BARDI, G., ANDERSEN, J.A., MITELMAN, F. and HEIM, S., Clonal heterogeneity in breast cancer: karyotypic comparisons of multiple intra- and extra-tumourous samples from 3 patients. Int. J. Cancer, 63, 63-68 (1995).
34. TODD, J.H., DOWLE, C., WILLIAMS, M.R., ELSTON, C.W., ELLIS, I.O., HINTON, C.P., BLAMEY, R.W. and HAYBITTLE, J.L., Confirmation of a prognostic index in primary breast cancer. Brit. J. Cancer, 56, 489-492 (1987).
35. TUBIANA, M. and KOSCIELNY, S., Natural history of human breast cancer: recent data and clinical implications. Breast Cancer Res. Treat., 18, 125-140 (1991).